Jane Greenhalgh
Jane Greenhalgh is a senior producer and editor on NPR's Science Desk.
She produces the weekly Health segment on NPR's Morning Edition and writes and edits for NPR's health blog, "Shots." Greenhalgh also produces stories on science, health, and global health across NPR's many platforms.
Greenhalgh was part of the team of broadcast, digital, and multimedia journalists who produced the 2015 award-winning series "#15Girls," which examined the struggles teenage girls face throughout the developing world. Greenhalgh's story "Banished to the Shed" was one of NPR's most listened to and viewed stories of 2015.
She has twice won The American Association for the Advancement of Science award: In 2020 for her work on Victoria's Story: Gene editing helps people with sickle cell, and for NPR's 2014 series "The human microbiome: guts and glory." Greenhalgh also won The National Academies of Science Communication award in 2014, and she was part of the digital team which won for the 2009 series Climate Connections. She traveled extensively for this year-long, multi-platform project, examining how climate change is affecting people across the globe. From Timbuktu, where the desert nomads are giving up their way of life, to Peru, where potato farmers are moving their crops higher up the mountain, and to Bangladesh, where scientists are experimenting with drought and flood resistant rice, the stories Greenhalgh produced chronicled the impact of climate change.
Greenhalgh has traveled extensively covering health issues in developing countries, including cholera in Haiti, polio in Indonesia, tuberculosis in Kenya, AIDS in India, malaria in the Gambia, malnutrition in Bolivia, and menstrual health in Nepal.
-
People who are 50 and older and certain immunocompromised individuals may get a second Pfizer-BioNTech or Moderna COVID-19 vaccine booster four months after they received the first. -
Those who contracted COVID-19 can end their isolation after five days while continuing to wear a well-fitting mask for an additional five days, according to the agency. -
The Food and Drug Administration is expected to announce later this week that it is authorizing boosters for people 18 or older, even if they aren't at risk for severe disease. -
Kids ages 5 to 11 will soon be able to get Pfizer's low-dose COVID vaccine. CDC director Rochelle Walensky agreed with a unanimous decision of a team of advisers that the benefits outweigh the risks. -
Moderna submitted data from 344 volunteers who got a third shot of the vaccine six months after their first two doses. The additional shot significantly boosted immunity, the company said. -
People with weakened immune systems who already got two doses of the Pfizer or Moderna COVID-19 vaccines can now get a third shot. But exactly who is eligible? Here's what we know so far. -
The FDA amended its emergency use authorizations for the Pfizer and Moderna vaccines to allow for an additional dose for some immunocompromised people. -
The CDC information dated Thursday gives new details on this variant of the coronavirus and says the agency should "acknowledge that the war has changed." It was first reported by The Washington Post. -
The CDC says COVID-19 was the largest factor, along with drug overdoses, homicides, diabetes and chronic liver disease. The decline was even greater for Hispanic men.
-
The CDC released new estimates showing the highly contagious delta variant now accounts for more than 51% of cases in the U.S. In some parts of the country, the strain is responsible for 80% of cases.
